Click Here for 5% Off Your First Aladdin Purchase!

Name And Identifier

ID: ALA1774702

Max Phase: Preclinical

Molecular Formula: C8H8INO2

Molecular Weight: 277.06

Molecule Type: Small molecule

Representations

Molfile:

Canonical SMILES:

copy

Standard InChI:

copy

Standard InChI Key:

copy

Alternative Forms

  1. Parent:

    ALA1774702

    ---

Molecule Features

Natural Product: NoChemical Probe: No
Molecule Type: Small moleculeFirst In Class: No
Chirality: NoProdrug: No
Oral: NoParenteral: No
Topical: NoBlack Box: No
Availability: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for Indication

Mechanisms of Action

Mechanism of ActionAction TypeTarget NameTarget TypeTarget OrganismBinding Site Name

Activity Summary

Bioactivity SummaryCount
GI504
Assay SummaryCount
F-Functional4

Properties

Molecular Weight: 277.06Molecular Weight (Monoisotopic): 276.9600
AlogP: 2.57#Rotatable Bonds: 3
Polar Surface Area: 43.14Molecular Species:
HBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3
HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa:
CX LogP: 3.40CX LogD: 3.40
Aromatic Rings: 1Heavy Atoms: 12
QED Weighted: 0.37Np Likeness Score: -1.19

References

1. Pinto O, Sardinha J, Vaz PD, Piedade F, Calhorda MJ, Abramovitch R, Nazareth N, Pinto M, Nascimento MS, Rauter AP..  (2011)  Synthesis of tetrahydronaphthalene lignan esters by intramolecular cyclization of ethyl p-azidophenyl-2-phenylalkanoates and evaluation of the growth inhibition of human tumor cell lines.,  54  (9):   [PMID:21504224]

Source

Source(1):

  • Scientific Literature